Evolus Receives Regulatory Approval for Nuceiva® in Australia

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/31/2026

1. PCG
2. NVDA
3. AVGO
4. ALNY
5. CNS
6. EC
7. APO
8. SRE
9. ATTO
10. BRVE

Go back to Evolus Receives Regulatory Approval for Nuceiva® in Australia
(NASDAQ: EOLS) Delayed: 8.98 +0.10 (1.13%)
Previous Close $8.88    52 Week High $ 
Open $8.85    52 Week Low $ 
Day High $9.03    P/E N/A 
Day Low $8.75    EPS $ 
Volume 344,661